The U.S. Food and Drug Administration (FDA) amended the Moderna COVID-19 vaccine emergency use authorization to authorize use for all patients 6 months through 17 years of age. The U.S. Centers for Medicare & Medicaid Services (CMS) issued 7 new Current Procedural Terminology (CPT) codes effective June 17, 2022.
Code 91311 For Vaccine Product:
- Long descriptor: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage, for intramuscular use
- Short descriptor: SARSCOV2 VAC 25MCG/0.25ML IM
Code 0111A For Vaccine Administration, First Dose:
- Long descriptor: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; first dose
- Short descriptor: ADM SARSCOV2 25MCG/0.25ML1ST
Code 0112A For Vaccine Administration, Second Dose:
- Long descriptor: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; second dose
- Short descriptor: ADM SARSCOV2 25MCG/0.25ML2ND
Code 0113A For Vaccine Administration, Third Dose:
- Long descriptor: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 25 mcg/0.25 mL dosage; third dose
- Short descriptor: ADM SARSCOV2 25MCG/0.25ML3RD
Code 0091A For Vaccine Administration, First Dose:
- Long descriptor: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage; first dose, when administered to individuals 6 through 11 years
- Short descriptor: ADM SARSCOV2 50 MCG/.5 ML1ST
Code 0092A For Vaccine Administration, Second Dose:
- Long descriptor: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage; second dose, when administered to individuals 6 through 11 years
- Short descriptor: ADM SARSCOV2 50 MCG/.5 ML2ND
Code 0093A For Vaccine Administration, Third Dose:
- Long descriptor: Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage; third dose, when administered to individuals 6 through 11 years
- Short descriptor: ADM SARSCOV2 50 MCG/.5 ML3RD
Source: U.S. Centers for Medicare & Medicaid Services (CMS)
About 3Gen
3Gen Consulting has always been in the forefront when it comes to adding value. We always believe in setting our own standards. What sets us apart is the investment that we make in our people, processes and innovation to provide you with market leading healthcare revenue cycle management services. We work as an extension of our clients’ teams by focusing on their key challenges, aligning with their culture and delivering the best results.
If you’re interested in finding the right medical billing and coding services partner, contact us today.
